
This study investigates the feasibility of utilizing fluorescently labelled tilmanoscept in sentinel lymph node biopsy (SLNB) for oral cancer. The findings demonstrate a high accuracy level, particularly in identifying cervical sentinel nodes. The real-time fluorescence imaging employed during the procedure enhances the precision of SLNB, presenting promising prospects for improving the diagnosis and treatment of oral cancer.
Like
Save
Share